A phase IIa, randomized, parallel, double-blind, Placebo Controlled Study to Evaluate the Efficacy and safety of enpatoran in de

A phase IIa, randomized, parallel, double-blind, Placebo Controlled Study to Evaluate the Efficacy and safety of enpatoran in dermatomyositis and polymyositis participants receiving standard of care.

Abierta

Código protocolo: MS200569_0041
Código EudraCT: _
Grupo de investigación: Enfermedades Sistémicas
Servicio: Medicina Interna
Investigador/a principal: Selva O'Callaghan, Albert
Patología: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
Fase: Fase II